Results 191 to 200 of about 178,608 (254)

Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies. [PDF]

Eur Respir J
Hoeper MM, Gomberg-Maitland M, Badesch DB, Gibbs JSR, Grünig E, Kopeć G, McLaughlin VV, Meyer G, Olsson KM, Preston IR, Rosenkranz S, Souza R, Waxman AB, Perchenet L, Strait J, Xing A, Manimaran S, Wang X, Miller B, Cornell AG, de Oliveira Pena J, Ghofrani HA, Humbert M.   +22 more
europepmc   +1 more source

Evolving ONe WD+He star systems to intermediate-mass binary pulsars [PDF]

, 2018
Dongdong Liu, Bo Wang, Wen‐Cong Chen, Zhao-Yu Zuo, Zhanwen Han   +4 more
openalex   +1 more source

Radiation-Associated Aortocolonic Fistula in Urothelial Carcinoma: Multidisciplinary Management and Case Report. [PDF]

Clin Case Rep
Lee M, Pillai AK, Fan C, Cai Q, Baker K, Wang J.   +5 more
europepmc   +1 more source

Influence of pressure anisotropy and non-metricity parameter on mass-radius relation and stability of millisecond pulsar in $f(Q)$ gravity [PDF]

S. K. Maurya, Ksh. Newton Singh, G. Mustafa, Megandhren Govender, Abdelghani Errehymy, Abdul Aziz   +5 more
openalex   +1 more source

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol. [PDF]

BMC Cancer
Courtney PT, L Santoso M, Savjani RR, K Reddy V, Chai-Ho W, Velez Velez MA, J Wong D, Palodichuk C, Basehart TV, P O'Connell D, Cao M, Telesca D, Chin RK.   +12 more
europepmc   +1 more source

Broadband x-ray imaging and spectroscopy of the crab nebula and pulsar with <i>NuSTAR</i>

, 2015
Kristin K. Madsen, Stephen P. Reynolds, Fiona A. Harrison, Hongjun An, Steven E. Boggs, Finn E. Christensen, William W. Craig, Chris L. Fryer, Brian W. Grefenstette, Charles J. Hailey   +9 more
openalex   +1 more source

Finite velocity effect of ultralight vector dark matter in pulsar timing arrays [PDF]

Qing-Hua Zhu
openalex   +1 more source

Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration. [PDF]

Ther Adv Ophthalmol
Lanzetta P, Korobelnik JF, Heier JS, Leal S, Holz FG, Clark WL, Eichenbaum D, Iida T, Sun X, Berliner AJ, Schulze A, Schmelter T, Schmidt-Ott U, Zhang X, Vitti R, Chu KW, Reed K, Rao R, Bhore R, Cheng Y, Wong TY.   +20 more
europepmc   +1 more source

Understanding the PULSAR effect in combined radiotherapy and immunotherapy using transformer-based attention mechanisms. [PDF]

Front Oncol
Peng H, Moore C, Saha D, Jiang S, Timmerman R.   +4 more
europepmc   +1 more source

Efficacy of Aflibercept 8 mg in Pretreated Age-Related Macular Degeneration. [PDF]

J Clin Med
Palm C, Zweifel SA, Gabathuler F, Cozzi M, Fasler K.   +4 more
europepmc   +1 more source